Orto

Startup

Orto Bio Ltd. is a research company using novel techniques to identify naturally immunogenic and protective epitopes to be incorporated into the next generation of vaccines to provide broad protection against target pathogens. Our key focus is to identify and develop novel protective antigens to be used to develop vaccines to a variety of viral and bacterial pathogens.  We are currently demonstrating our approach by developing a pan-influenza vaccine based on epitopes which are limited in variability and allow us to produce a naturally immunogenic broadly protective vaccine designed to avoid the need for reformulation each year. 

website